GF Fund Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2K Sell
1,141
-58
-5% -$573 ﹤0.01% 526
2026
Q1
$11.7K Buy
1,199
+142
+13% +$1.3K ﹤0.01% 547
2025
Q4
$10.1K Sell
1,057
-98
-8% -$998 ﹤0.01% 573
2025
Q3
$11.3K Sell
1,155
-222
-16% -$1.71K ﹤0.01% 547
2025
Q2
$8.36K Hold
1,377
﹤0.01% 587
2025
Q1
$17K Buy
1,377
+247
+22% +$3.49K ﹤0.01% 516
2024
Q4
$15.7K Buy
+1,130
New +$17.8K ﹤0.01% 493

Other funds holding PRTA

GF Fund Management's PRTA Position: Q2 2026 in Review

GF Fund Management reduced its Prothena Corp (PRTA) stake by 4.8% in Q2 2026, selling an estimated $573 and leaving 1,141 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #526.

GF Fund Management first reported a position in PRTA in Q4 2024 and has held it in 7 quarters since. The position peaked at $17K in Q1 2025. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • GF Fund Management held 1,141 shares of Prothena Corp worth $11.2K as of Q2 2026.
  • GF Fund Management sold 58 Prothena Corp shares in Q2 2026, an estimated $573.
  • Prothena Corp made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #526 holding.
  • GF Fund Management first reported a position in Prothena Corp in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Prothena Corp position peaked at $17K in Q1 2025.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.